Mj. Gitlin et al., Fluphenazine levels during maintenance treatment of recent-onset schizophrenia: relation to side effects, psychosocial function and depression, PSYCHOPHAR, 148(4), 2000, pp. 350-354
Rationale: The utility of fluphenazine levels during maintenance treatment
of schizophrenia is still unclear Objectives: This study investigated the r
elationship between fluphenazine levels and a variety of clinical measures
during maintenance treatment of schizophrenia. Methods: Fluphenazine levels
, side effects, depression and psychosocial outcome were measured at five t
ime points over approximately 1 year in 59 recent onset schizophrenic patie
nts treated with a maintenance dose of injectable fluphenazine decanoate. N
egative symptoms were evaluated at the 1-year endpoint. Results: Fluphenazi
ne levels showed mt;ked intraindividual variability even when measurements
were restricted to the second 6 months of treatment, by which time steady s
tate levels should have been achieved. No consistent relationship was found
between fluphenazine levels and any of the outcome measures. Conclusions:
The results of this study suggest that fluphenazine plasma levels do not ro
utinely add relevant clinical information beyond that of dose in evaluating
potential side effects or negative consequences during maintenance treatme
nt with the decanoate form of the medication.